Immuno 5 - Autoinflammatory and Autoimmune disease Flashcards

1
Q

Immunopathology in the absence of infection

Innate Immune response
Adaptive immune response

A

Innate Immune response -> auto-inflammatory
Local factors at sites predisposed to disease lead to activation of innate immune cells such as macrophages and neutrophils, with resulting tissue damage

Adaptive immune response -> auto-immune
 Aberrant T and B cell responses in primary (where they are produced) and secondary lymphoid organs (where they encounter an antigen) breaking of tolerance  development of immune reactivity towards self-antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classical presentation of monogenic auto-inflammatory diseases

A

Periodic fevers
Skin/ joint/ serosal/ CNS inflammation
High CRP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

FMF gene, protein, inheritance

A

Monogenic autoinflammatory disease

MEFV gene
Pyrin-Marenostrin protein
AR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathogenesis of FMF

A

MEFV mutation
Inactivation of pyrin-marenostrin
Failure to regulate cryopyrin

Cryopyrin activates apoptosis associated speck like protein (ASC) –> increases expression of procaspase 1

Increased production of IL1, NFkappa B –> TNFa
Apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is NFkappaB

A

TF that regulates expression of genes involved in immunity e.g. TNFa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

FMF clinical presentation

A

3 Ps

o	Periodic fevers lasting 48-96 hours, associated with
o	Abdominal pain (peritonitis)
o	Chest pain (pleurisy and pericarditis)
o	Arthritis 
o	Rash
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

FMF mx

A

o Clochicine 500ug BD
 Binds to tubulin in neutrophils  disrupts neutrophil functions incl. migration + chemokine secretion
 Baseline treatment

o IL-1 blocker  anakinra, canukinumab

o TNFα blocker  Etanercept

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

FMF complication

A

AA amyloidosis

deposition in kidney most clinically important - nephrotic syndrome (proteinuria) + renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Give 3 examples of monogenic auto-immune diseases

A

IPEX - immune dysregulation, polyendocrinopathy, enteropath, X-linked syndrome - abnormality of regulatory T cells

ALPS - autoimmune lymphoproliferative syndrome - abnormality of lymphocyte apoptosis

APS1 - APECED - Autoimmune polyendocrine syndrome Type 1 - Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy syndrome - abnormality in tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

IPEX

Inheritance
Mutation
Effect
Sx

A

Xliked

foxp3 (forkhead box 3)
TF, required for the development of regulatory T cells

failure to negatively regulate T cell responses –> failure of peripheral T cell tolerance –> Alloreactive B cells –> autoantibody formation

“DM, Diarrhoea (enteropathy), dermatitis (eczema), hypothyroidism”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ALPS

Inheritance
Mutation
Effect
Sx

A

AD

Mutation in FAS pathway
failure of apoptosis of T cells in thymus –> no central tolerance –> failure of lymphocyte homeostasis

lymphocytosis + lymphadenopathy + lymphoma (double negative cells CD4-, CD8-) + large spleen
Autoimmune diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

APS1 - APECED

Inheritance
Mutation
Effect
Sx

A

AR

AIRE (autoimmune regulator) defect - TF involved in the development of T cell tolerance in the thymus - upregulates expression of self-antigens by thymic cells and promotes spoptosis
Defect in AIRE - failure of central tolerance - autoreactive T and B cells

Hypoparathyroidism, Hypothyroidism
Addison’s, Vitiligo
Diabetes, Enteropathy
Antibodies vs IL17, IL22 - candidiasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give examples of poly-genic autoinflammatory conditions

A

o IBD – CD, UC
o Osteoarthritis
o GCA
o Takayasu’s arteritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which gene is implicated in CD?

A

IBD1 gene on Chr 16 identified as NOD2

NOD 2
 Gene
 Expressed in cytoplasm of myeloid cells – macrophages, neutrophils, dendritic cells
 Cytoplasmic microbial sensor  recognizes muramyl dipeptide on bacterial products  stimulates NFK-beta ( TNFa)  promotes clearance of bacterial products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Give examples of mixed pattern diseases

A

o Axial spondylarthritis - Ankylosing spondylitis
o Psoriatic arthritis
o Behcet’s syndrome

  • HLA associations may be present
  • Auto-antibodies not usually a feature (having auto-antibodies is usually classified as an autoimmune disease)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

o Axial spondyloarthritis - Ankylosing spondylitis HLA associations + Interleukins

A

HLAB27 - presents antigen to CD8 - ligand for killer immunoglobulin receptor

IL23R - IL23 promotes th17 cell differentiation

ILR2 - inhibits activity of IL1 - reduced TNFa production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

o Axial spondyloarthritis - Ankylosing spondylitis treatment

A

NSAIDs

Anti-TNFa

Anti-IL17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Which of the following is an example of a monogenic auto-inflammatory disease?

Familial Mediterranean fever
Graves’ disease
Crohn’s disease
Axial spondyloarthritis
IPEX syndrome due to FoxP3 mutation
A

Familial Mediterranean fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which of the following is an example of a monogenic auto-immune disease?

Familial Mediterranean fever
Graves’ disease
Crohn’s disease
Axial spondyloarthritis
IPEX syndrome due to FoxP3 mutation
A

IPEX syndrome due to FoxP3 mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Which of the following is an example of a polygenic auto-inflammatory disease?

Familial Mediterranean fever
Graves’ disease
Crohn’s disease
Axial spondyloarthritis
IPEX syndrome due to FoxP3 mutation
A

Crohn’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Polygenic Auto-immune disease

2 genetic polymorphisms that are associated with T cell activation

A

PTPN22
Protein tyrosine phosphatase non-receptor 22
Lymphocyte specific tyrosine phosphatase which suppresses T cell activation

CTLA4
Cytotoxic T lymphocyte associated protein 4
Receptor for CD80/CD86 expressed by T cells
Expressed by T cells transmits inhibitory signals to control T cell activation

22
Q

HLA associations

Goodpasture disease
Graves disease
Hashimotos
SLE 
T1DM
Addison's disease
Rheumatoid arthritis
Ankylosing spondylitis
A

Goodpasture disease
HLADR 15
HLA DR2

Graves disease
HLA DR3

Hashimotos
HLADR3 HLADR5

SLE
HLA DR3

T1DM, Addison’s disease
HLADR3 HLADR4

Rheumatoid arthritis
HLADR4
HLADR1

Ankylosing spondylitis
HLA B27

23
Q

Describe the 4 types of hypersensitivity reactions

A

Type I: Anaphylactic hypersensitivity
- Immediate hypersensitivity which is IgE mediated – rarely self antigen

Type II: Cytotoxic hypersensitivity
- Antibody reacts with cellular antigen

Type III: Immune complex hypersensitivity
- Antibody reacts with soluble antigen to form an immune complex

Type IV: Delayed type hypersensitivity
- T-cell mediated response

24
Q

Describe the two mechanisms of T2 hypersensitivity reaction

A

o Antibody dependent destruction (NK cells (release of cytolytic granules and membrane attack), phagocytes, complement (complement activation + cell lysis))

o Receptor activation or blockade (sometimes considered Type V response)

25
Q

Type II hypersensitivity reaction
Auto-antigens to the following syndromes

Goodpasture disease
Pemphigus vulgars
Graves disease
Myasthenia gravis
Pernicious anaemia
A

IgG or IgM antibodies

Goodpasture disease
non-collagenous domain of basement collagen type IV

Pemphigus vulgaris
Epidermal cadherin

Graves disease (IgG antibodies)
Thyroid stimulating hormone receptor

Myasthenia gravis
Anti-cholinesterase receptor

Pernicious anaemia
Anti - intrinsic factor antibody
anti-gastric parietal cell antibody

26
Q

What do type III reactions affect?

Characteristic symptom
Other sx

A

Inflammation and damage to vessels
Immune complex deposition in blood vessels

Purpuric skin rash - very characteristic of type III reaction

Cutaneous vasculitis
Glomerulonephritis
Arthritis

27
Q

Type IV hypersensitivity - tissue destruction by 2 ways

A

Th1 cells activated by APC
when the antigen is presented again in the future, the memory Th1 cells will activate macrophages and cause an inflammatory response

 HLA class 1 present self-antigens to CD8 T cells → cytolytic granule release from primed CD8 T-cell  cell lysis

 HLA class 2 present self-antigen to CD4 T cells* → cytokine production (e.g. IFN-γ) → TNF induction + Lymphotoxin + HLA upregulation (macrophage)  inflammation and tissue damage

*CD80/86 receptor on APC interacts with CD28 receptor on CD4

28
Q

Type III hypersensitivity reaction
Auto-antigens to the following syndromes

SLE

A

IgG antibodies

SLE
DNA, Histones, RNP (ribonucleoprotein)

29
Q

Type IV hypersensitivity reaction
Auto-antigens to the following syndromes

Insulin dependent DM
Rheumatoid arthritis
Multiple sclerosis
Coeliac disease

A

Insulin dependent DM
Pancreatic b cell antigen
Glutamic acid decarboxylase(GAD65)
Islet antigen 2 (IA2)

Rheumatoid arthritis
Unknown synovial joint antigen
anti-ccp
anti-RF

Multiple sclerosis
Myelin basic protein
myelin oligodendrocyte protein
proteolipid protein

Coeliac disease
Anti - tissue transglutaminase antibodies
Anti-endomyosial antibody

30
Q

Autoantibodies in Hashimoto’s thyroiditis

What kind of hypersensitivity reaction is it?

A

Anti-thyroid peroxidase antibodies

Anti-thyroglobulin antibodies

o Not useful to measure anti-TG and anti-TPO antibodies as there is a high prevalence in the normal population with no symptoms  just do thyroid biochemistry

Both T2 + T4 hypersensitivity reaction

31
Q

pathogenesis of T1DM

A

T IV hypersensitivity rxn

CD8 T cells infiltrate the pancreas and destroy islet cells

Auto antibodies
glutamic acid dehydrogenase 65 (GAD65)
Islet antigen 2 (IA2)

Antibodies that predate the development of the disease

Anti-islet cell antibodies
Anti-insulin ab
Anti-GAD ab
Anti-IA2 antibodies

32
Q

Goodpasture’s disease ix

A

o Ix
 Anti-glomerular basement membrane antibody +ve
 Crescentic nephritis on biopsy

o Detection of auto-antibodies in kidney
 Fluorescein conjugated polyclonal anti-human Ig targets auto-antibody which targets the BM
 Smooth linear deposition of antibody along the glomerular basement membrane

Type II hypersensitivity reaction
autoantibody targets non collagenous domain of basement membrane collagen type IV

33
Q

Genetic predisposition in rheumatoid arthritis

A

HLA DR 4 HLA DR 1
PTPN22 polymorphism
PADI2, PADI4* polymorphism

  • peptidyl arginine deiminase
    • Enzymes involved in deamination of arginine to create citrulline
    • These polymorphisms are associated with higher levels of citrullination
    • This creates a high load of citrullinated proteins
34
Q

Which infection is associated with rheumatoid arthritis and why

A

• Porphyromonas gingivalis expresses PAD enzyme  promotes citrullination

35
Q

Antibodies in rheumatoid arthritis

A
  • Anti cyclic citrullinated peptide (Anti-CCP antibody)
    best blood test for the dx of Rheumatoid arthritis

-Rheumatoid factor
rheumatoid factor is an antibody direct against the common Fc region of human IgG
(IgM anti-IgG)

36
Q

Anti nuclear ab stainng

A

Test by staining Hep-2 cells (human epidermoid cancer line)

37
Q

Pathophysiology of SLE

A

Type III hypersensitivity reaction

Abnormalities in cellular activation –> B cell hyperactivity + loss of tolerance
Abnormalities in clearance of apoptotic cells

Antibodies directed against intracellular proteins
Antibodies bind to antigen to form immune complexes

Immune complexes

1) deposit in tissues
2) activate complement
3) stimulate cells expressing Fc and antigen receptors

lumpy-bumpy’ pattern of antibodies bound to immune complexes with fluorescein conjugated anti-human Immunoglobulin.

38
Q

You request an anti nuclear antibody test on two patients with joint pain
Patient A’s result is 1:640
Patient B’s result is 1:80
Based on this information, which has the “strongest” (i.e most positive) antibody?

A

Patient A’s result is 1:640

titre = the minimal dilution at which the antibody can be detected

 Measured by titre (minimal dilution at which antibody can be detected)
 I.E. 1: 640 means it has taken 640 dilutions to get to minimal concentration – this means that the antibody is very strong as at 640 dilutions it is still present (very strong antibody)
 I.E. 1: 60 means it has only taken 60 dilutions to get minimal concentration (very weak antibody)

39
Q

Targets of ANA (ANA can stain)

A

dsDNA

Anti-ENA ab (extractable nuclear antigens) - ab associated with ribonucleoproteins
Ro, La, Sm, U1RNP

Anti-topoisomerase AB (Anti-SCL70 AB)

Centromere

40
Q

ELISA staining pattern for

dsDNA
ENA (extractable nuclear antigens)

A

dsDNA - homogenous staining

ENA - speckled antibody

41
Q

Anti-dsDNA antibody

A

Homogenous staining on ELISA
Highly specific for SLE
Very high titres often associated with more severe disease incl. renal + CNS involvement
Titres useful in disease monitoring

(vs anti-ENA ab where titres are not helpful in disease monitoring)

42
Q

Measuring complement in SLE

A

 Quantitation of C3 + C4 acts as a surrogate marker of disease activity

 Depletion of C4 occurs first [FOUR = FIRST] and then depletion of C3

 We measure inactivated complement proteins, not activated forms
 (formation of antibody-antigen immune complexes – activate complement cascade via classical pathway – complement components become depleted if constantly consumed-can act as a marker of disease activity)

43
Q

APL syndrome ab

A

Lupus anti-coagulant
Anti-cardiolipin
Anti-B2 glycoprotein 1

44
Q

Limited CREST

Diffuse CREST

ab
features

A

limited (does not progress beyond forearms) - anti-centromere ab

Diffuse (progresses beyond forearms) - anti-topoisomerase ab (anti-scl70)

(CREST=)
Calcinosis
Raynaud's
Oesophageal dysmotility
Sclerodactyly 
Telangiectasia
Pulmonary HTN
45
Q

Dermatomyositis vs
Polymyositis

ab

A

o Dermatomyositis (skin involvement – periorbital rash + Gottron’s papules)
 Within muscle – perivascular CD4 T cells and B cells
 Immune complex mediated vasculitis – T3 response

o Polymyositis (no skin involvement – no rash)
 Within muscle – CD8 T cells surround HLA Class I expressing myofibres
 CD8 T cells kill myofibres via perforin/granzymes – T4 response

o Investigations
 Positive ANA (in some patients) – Extended myositis panel
o Anti-aminoacyl transfer RNA synthetase antibody  Anti-Jo-1 (cytoplasmic)
o Anti-SRP (Anti-signal recognition peptide antibody) (nuclear + cytoplasmic) (PM)
o Anti-Mi2 (nuclear) (DM>PM)

46
Q

ANA +ve connective tissue diseases

anti-dsDNA
anti-ENA

A

anti-dsDNA
SLE

anti-ENA

  • Ro, La, Sm, RNP - SLE (all), Sjogrens (Ro, La)
  • scl70 (diffuse cutaneous systemic sclerosis (CREST))
  • centromere (limited cutaneous systemic sclerosis (CREST)

Cytoplasmic
aminoacyl transfer RNA synthetase ab Jo-1 (Myositis)

47
Q

ANCA associated vasculitis

A

o Microscopic polyangiitis / Microscopic polyarteritis / MPA
o Granulomatosis with polyangiitis / Wegener’s granulomatosis / GPA
o Eosinophilic granulomatosis with polyangiitis / Churg-Strauss syndrome / eGP

48
Q

What is ANCA

A

Anti neutrophil cytoplasmic antibody

o Antibodies specific for antigens located in primary granules within the cytoplasm of neutrophils
o Inflammation may lead to expression of these antigens on cell surface of neutrophils  antibody engagement with cell surface antigens may lead to neutrophil activation (type II hypersensitivity)  activated neutrophils interact with endothelial cells causing damage to vessels  vasculitis

o Help in diagnosis and monitoring of disease activity

49
Q

cANCA vs pANCA

A

cANCA
Cytoplasmic fluorescence
Associated with antibodies to enzyme proteinase 3
granulomatous polyangiitis with renal involvement

pANCA
Perinuclear staining pattern
Associated with antibodies to myeloperoxidase
Less sensitive and specific than cANCA
microscopic polyangiitis and eosinophilic granulomatous polyangiitis

50
Q

Learn autoantibody tables

A

p.25